Dr. Colgan has over a decade of experience in the digital pathology sector and is focused on how this new and disruptive technology can be leveraged to provide real benefits in both the healthcare and research domains. Prior to working with Leica Biosystems, she came from a research background with a BSc in Biotechnology and a PhD in Vascular Biology from Dublin City University, Ireland.
Die digitale Pathologie umfasst die Erfassung, Verwaltung, Weitergabe und Interpretation von pathologischen Informationen, einschließlich Objektträgern und Daten, in einer digitalen Umgebung
